Expanded group publisher role reflects how HVAC, plumbing, and mechanical systems professionals operate today.

BIRMINGHAM, MI / ACCESS Newswire / January 20, 2026 / BNP Media announced today an expansion of leadership across its mechanical industry portfolio, appointing Sarah Harding as Group Publisher of Plumbing & Mechanical and Supply House Times, in addition to her current role as Publisher of The ACHR NEWS. The ACHR NEWS portfolio includes SNIPS NEWS, Engineered Systems NEWS, and Distribution Trends.

This leadership alignment reflects both the way the mechanical systems industry already operates and BNP Media’s mission to drive industries forward through authentic content, engaged communities, and meaningful connections. HVAC, plumbing, and mechanical systems professionals often serve overlapping roles, audiences, and markets. Bringing these brands together under unified leadership strengthens BNP Media’s ability to serve those professionals with greater clarity, consistency, and industry relevance.

Harding brings more than 25 years of experience in B2B media and publishing, with deep expertise in mechanical systems and multi-brand portfolio leadership. Since taking on leadership of The ACHR NEWS in 2022, she has overseen sustained audience growth, expanded digital offerings, and continued investment in content that supports contractors, engineers, and industry decision-makers. In 2026, The ACHR NEWS is also marking its 100th anniversary, underscoring the brand’s long-standing role within the HVAC community.

"HVAC, plumbing, and mechanical systems professionals do not work in silos, and the media that supports them should not either," Harding said. "This allows us to better reflect how the industry actually functions and to create stronger connections across the communities we serve. My focus is on ensuring these brands continue to deliver practical, credible, and forward-looking content that helps our audiences succeed."

"This leadership alignment reflects our commitment to serve industries the way they actually operate," said Tagg Henderson, Co-CEO of BNP Media. "By bringing related mechanical systems communities together under experienced leadership, we strengthen our ability to deliver credible content, foster meaningful connections, and support long-term growth across the industry."

BNP Media’s mechanical systems industry brands will continue to operate as distinct publications, while benefiting from shared leadership, strategy, and collaboration. This approach supports advertisers, readers, and partners by providing more integrated access to the HVAC, plumbing, and mechanical markets.

For advertising inquiries related to Plumbing & Mechanical and/or Supply House Times, please contact Jim McLaughlin at mclaughlinj@bnpmedia.com.

About BNP Media

BNP Media is a fourth-generation, family-owned media company serving B2B industries through trusted brands including The ACHR NEWS, Plumbing & Mechanical, and Supply House Times, events, research, and digital marketing services. Founded in 1926, BNP Media is committed to supporting professional communities with credible information, strong connections, and solutions that help businesses move forward.

For more information about this announcement, please contact Sarah Harding, Group Publisher at BNP Media, at hardings@bnpmedia.com.

SOURCE: BNP Media

View the original press release on ACCESS Newswire

LOS ANGELES, CALIFORNIA / ACCESS Newswire / January 20, 2026 / The entertainment PR and marketing powerhouse 42West, a subsidiary of Dolphin (NASDAQ:DLPN), will showcase a number of impressive clients with film and television projects premiering at the 2026 Sundance Film Festival, running in Park City from January 22 to February 1.

42West’s slate at Sundance features nine projects spanning six programming areas, highlighting the company’s expansive presence across documentary, narrative, and episodic content. All the titles are actively seeking distribution. Premiering in the U.S. Documentary Competition are Sharon Liese’s SEIZED, Rachel J.Morrison’s JOYBUBBLES, and Jason Osder and William Lafi Youmans’ WHO KILLED ALEX ODEH?. In the U.S. Dramatic Competition, Liz Sargent’s TAKE ME HOME, starring Anna Sargent, Victor Slezack, and Ali Ahn. The NEXT program, presented by Adobe, features Valerie Veatch’s documentary GHOST IN THE MACHINE and Georgia Bernstein’s NIGHT NURSE, starring Cemre Paksoy, Bruce McKenzie, Eléonore Hendricks, and Mimi Rogers. In the Midnight program is Casper Kelly’s BUDDY starring Cristin Milioti, Delaney Quinn, Topher Grace, Keegan-Michael Key, Michael Shannon, and Patton Oswalt. The Family Matinee section showcases Alysa Nahmias’ COOKIE QUEENS executive produced by Prince Harry and Meghan, the Duke and Duchess of Sussex. Rounding out the slate in the Episodic section is Alec Goldberg’s SOFT BOIL, co-written with and starring Camille Wormser alongside John Gemberling and Madison Shamoun. 42West is also partnering with IndieWire, a leading film and television publication, to curate and book its festival programming slate, including the IndieWire Studio and Future of Filmmaking keynote and panels.

All nine projects are actively seeking distribution. 42West will work closely on the slate with numerous agencies including UTA Independent Film Group, Range Media Partners, Submarine, WME Independent, CAA Media Finance, Gersh, and MPI Media Group.

Additionally, 42West client Madison Wells is an executive producer on THE BADDEST SPEECHWRITER OF ALL, directed by Ben Proudfoot and Stephen Curry and produced by Proudfoot, Curry, and Erick Peyton, featured in the Documentary Short Film Program, that is also seeking distribution.

ABOUT 42WEST:

42West, a subsidiary of Dolphin, is one of the entertainment industry’s leading full-service public-relations firms. With offices in New York and Los Angeles, 42West has four divisions: Talent, Strategic Communications, Entertainment Marketing, and Fandoms & Franchises, the award-winning firm’s gaming, consumer products and publishing practice. The agency has developed and executed marketing and publicity strategies for hundreds of movies and television shows as well as countless actors, filmmakers, recording artists, personalities and authors. In addition, 42West provides strategic counsel to a wide variety of high-profile individuals and corporate clients – ranging from movie and pop stars to major studios, charitable organizations, and media conglomerates – looking to raise, reposition, or rehabilitate their public profiles.

ABOUT DOLPHIN:

Dolphin (NASDAQ: DLPN) is where cultural creation meets marketing execution. Founded in 1996 by Bill O’Dowd, Dolphin operates as both a venture studio – developing and investing in content, products, and experiences – and a marketing consortium featuring leading agencies across every communications discipline.

Dolphin’s collective includes 42West, The Door, Shore Fire Media, Elle Communications, Special Projects, and The Digital Dept., delivering expertise across film, television, music, influencers, sports, hospitality, fashion, consumer brands, and purpose-driven initiatives. Dolphin marketing has received numerous industry honors, including being named the #1 Agency of the Year by the Observer, as well as inclusion on the PR Net 100 and the PR News Elite 120.

This press release contains ‘forward-looking statements’ within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements may address, among other things, Dolphin Entertainment Inc.’s offering of common stock as well as expected financial and operational results and the related assumptions underlying its expected results. These forward-looking statements are distinguished by the use of words such as "will," "would," "anticipate," "expect," "believe," "designed," "plan," or "intend," the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, Dolphin Entertainment’s actual results may differ materially from the results discussed in its forward-looking statements. Dolphin Entertainment’s forward-looking statements contained herein speak only as of the date of this press release. Factors or events Dolphin Entertainment cannot predict, including those described in the risk factors contained in its filings with the Securities and Exchange Commission, may cause its actual results to differ from those expressed in forward-looking statements. Although Dolphin Entertainment believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be achieved, and Dolphin Entertainment undertakes no obligation to update publicly any forward-looking statements as a result of new information, future events, or otherwise, except as required by applicable law.

# # #

Contact:

James Carbonara
HAYDEN IR
(646)-755-7412
james@haydenir.com

SOURCE: Dolphin Entertainment

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 20, 2026 / New to The Street, the long-running, multi-platform business and financial media brand, today announced a record-breaking January 2026, with 22 companies signing new agreements and/or renewing for ongoing series participation, standalone television broadcasts, and/or iconic outdoor billboard programs during the month.

The signed and renewed engagements span long-form and multi-episode series, national and international linear television broadcasts, television commercial placements, high-impact outdoor billboard campaigns, executive and investor events, and long-form company biography productions, reflecting sustained demand for New to The Street’s modular, results-driven media offerings.

With its recent international expansion, New to The Street now delivers over 270 million television households weekly across U.S., MENA, and Latin American markets, creating one of the largest consistent linear distribution funnels in the business media category. This expanded linear footprint is directly fueling record growth across the company’s digital platforms, driving accelerated audience migration to its YouTube ecosystem and contributing to continued subscription momentum.

"January 2026 set a new benchmark for our organization," said Vince Caruso, CEO of New to The Street. "Companies are choosing platforms that deliver scale, flexibility, and continuity. Our expanded 270-million-plus weekly linear reach, combined with our ability to funnel that audience into digital and YouTube engagement, gives our clients sustained visibility while driving record growth across our owned media channels."

New to The Street’s performance continues to be driven by its series-based media model, enabling companies to maintain ongoing market presence while also offering standalone television and outdoor billboard programs for organizations seeking targeted, high-impact exposure. Clients may engage through series-only, TV-only, outdoor-only or fully integrated multi-channel campaigns, each designed to deliver predictable reach and measurable outcomes.

As the company progresses through 2026, New to The Street expects continued momentum supported by expanding international linear distribution, increasing demand for long-form company biographies, rising outdoor billboard adoption in major financial markets, and sustained digital subscriber growth driven by its television-to-digital funnel.

About New to The Street

New to The Street is a leading multi-platform business and financial media platform delivering series-based programming, standalone television broadcasts, and iconic outdoor billboard campaigns, alongside long-form company biographies, digital distribution, and executive-level events for public and private companies.

The platform is anchored by a 4.3 million-subscriber YouTube network and is complemented by a strategic NewsOut PR amplification partnership, accelerating the distribution of video press releases and breaking company news across digital, social, streaming, and connected TV channels.

In addition to its established U.S. footprint, New to The Street has recently expanded into the Middle East (MENA) and Latin America, increasing its total global linear television reach to more than 270 million households weekly. This scale positions New to The Street among the most expansive business media platforms operating globally while serving as a powerful funnel driving continued record subscription growth across its digital and YouTube platforms.

Through flexible engagement models – series, television-only, outdoor-only or fully integrated campaigns – New to The Street delivers predictable, scalable visibility across key global markets.

Media Contact:
Monica Brennan
Monica@NewtoTheStreet.com

SOURCE: New to The Street

View the original press release on ACCESS Newswire

SARASOTA, FLORIDA / ACCESS Newswire / January 20, 2026 / Specificity (OTCID:SPTY), a leading hybrid AdTech company specializing in bot-free, intent-based digital marketing solutions, today announced a series of milestones that underscore its robust financial health and positioning for accelerated growth in the coming year. These developments highlight the company’s commitment to delivering superior value to clients and shareholders alike, amid a rapidly evolving digital advertising landscape plagued by fraud and inefficiency.

In November 2025, Specificity achieved positive operating cash flow ahead of expectations, driven by a surge in new client acquisitions during the fourth quarter. This marks a pivotal shift toward sustainable profitability, with the company adding over $400,000 in annual run-rate revenue in December 2025 alone. "Our focus on human-verified, bot-free targeting is resonating with brands seeking real results," said Jason Wood, CEO of Specificity "By eliminating waste from fraudulent traffic, we’re not only boosting client ROI but also building a resilient business model that positions us for long-term success."

A standout achievement includes the company’s wildly successful inaugural month partnering with the third-largest travel website in Europe, which generates over $75 million annually. Leveraging Specificity’s proprietary AI-powered ad verification and intent data technologies, the campaign delivered an impressive 38X internal rate of return (IRR) through precise, fraud-free targeting. This collaboration exemplifies Specificity’s ability to drive measurable outcomes across industries, from travel and e-commerce to solar energy and retail, and many more, where clients have reported traffic increases of up to 217%, lead generation surges, and revenue growth in the hundreds of thousands.

Further bolstering its growth trajectory, Specificity recently signed a Letter of Intent (LOI) with Blackpearl Group to develop the world’s only fully integrated AdTech stack. This partnership aims to launch a direct challenge to Big Tech’s fraud-ridden ecosystems, combining Specificity’s audience resolution tools with advanced CRM integrations and first-party data building. Additionally, the company’s effective S-1 registration statement paves the way for access to expansion capital, enabling investments in proprietary technologies like Polygon for hyper-granular targeting and AI-driven analytics.

Financially, Specificity reported revenue of $260,000 for the quarter ending September 30, 2025, reflecting 21.7% growth quarter-over-quarter. Operating expenses declined 37.9% year-over-year to $162,754, demonstrating disciplined cost management. We are already hard at work putting together the 4Q numbers and look forward to releasing those results shortly. With billions of impressions served, many millions of website visits driven, and hundreds of millions in client revenue generated to date, Specificity continues to lead in creating clean, compliant data assets that empower brands in a post-cookie world.

"2025 was a breakthrough year, and 2026 will be one of serious expansion," added Wood. "Our hybrid model-blending creative agency expertise with cutting-edge AdTech-has proven its edge in combating the $84 billion annual fraud in digital advertising. We’re platform-agnostic, focusing on Connected TV (CTV), social, display, and automated workflows to reach high-intent audiences where they are. Investors can expect continued momentum as we capitalize on market shifts toward transparency and efficiency."

Specificity’s innovations have attracted the market’s attention and testimonials from long-term clients and new clients from both small business and enterprise level brands that can be seen on their website. As streaming surpasses traditional TV-with 85% of U.S. households subscribed to platforms and ad views up 45% since 2020-Specificity finds itself perfectly positioned to capture massive market share in this booming sector and has already developed technology to serve connected TV ads to high intent audiences.

For more information, visit www.specificityinc.com or contact investor relations at ir@specificityinc.com.

About Specificity

Specificity (OTCID:SPTY) is a Tampa-based digital marketing firm revolutionizing the industry through bot-free, intent-driven data and targeted advertising. By integrating agency services with advanced AdTech, Specificity helps brands eliminate fraud, build first-party audiences, and achieve superior ROI across channels. With billions of data points and impressions served, the company delivers results for clients nationwide.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Specificity undertakes no obligation to update these statements except as required by law.

SOURCE: Specificity Inc.

View the original press release on ACCESS Newswire

ATLANTIC CITY, NJ AND VANCOUVER, BC / ACCESS Newswire / January 20, 2026 / FendX Technologies Inc.(CSE:FNDX)(OTCQB:FDXTF)(FSE:E8D) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.

Carolyn Myers, CEO of FendX, will deliver a company presentation and be available for one-on-one investor meetings throughout the event to discuss the Company’s recent developments, growth strategy and investment opportunities.

Event Details:

• 3rd Annual DealFlow Discovery Conference

• The Borgata Hotel, Casino & Spa

• Atlantic City, NJ

• January 28-29, 2026

Investors interested in scheduling a meeting with the FendX management team should request an investor pass to attend the conference (no cost to attend).

About FendX Technologies Inc.

FendX is a surface protection company developing innovative solutions to help reduce the spread of harmful pathogens in everyday environments. Leveraging proprietary technologies, The Company is advancing a portfolio of protective surface coatings, including REPELWRAP™ film, a liquid-based nano- coating technology and a specialized Foley catheter coating. The Company is focused on building a robust intellectual property portfolio in the surface protection space and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across healthcare, consumer and commercial settings.

Media Contact:

Carolyn Myers
1-800-344-9868
investor@fendxtech.com

For more information, please visit https://fendxtech.com/ and the Company’s profile on SEDAR+ at www.sedarplus.ca.

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate, and that actual results and future events could differ materially from those anticipated in such statements.

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company’s public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company’s such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors should change.

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire

SHELTON, CT / ACCESS Newswire / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will participate in the DealFlow Discovery Conference, taking place January 28th and 29th, 2026.

Anil R. Diwan, PhD, President and Executive Chairman of the Company will deliver a company presentation on Thursday, January 29th at 11:00 am ET, and will be available for one-on-one investor meetings throughout the event.

NanoViricides is developing first-in-class antiviral drugs that act by a novel mechanism of action, enabling unparalleled broad-spectrum antiviral activity as well as safety. The Nanoviricides technology defines a novel antiviral mode of action that we call "Re-Infection Inhibition". A "nanoviricide™" is designed to look like a cell to the virus, presenting a high concentration of virus-binding ligands on its surface. Upon binding of the virus, the nanoviricide is further designed to change shape and engulf the virus particle, rendering it incapable of infecting cells.

Event Details:

• Conference: 3rd Annual DealFlow Discovery Conference

• Venue: The Borgata Hotel, Casino & Spa

• Location: Atlantic City, NJ

• Date: January 28th-29th, 2026

Investors interested in scheduling a meeting with the NanoViricides management team should request an investor pass to attend the conference by registering (no cost to attend) at the Conference website (https://dealflowdiscoveryconference.com/investors/ ).

ABOUT NANOVIRICIDES

NanoViricides, Inc. (the "Company") (www.nanoviricides.com) is a clinical stage company that is creating special purpose nanomaterials for antiviral therapy.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections. NV-387 is a unique broad-spectrum antiviral that is also effective in animal models for Monkeypox (MPox), Smallpox, as well as Measles.

Our other advanced drug candidate is NV-HHV-1 for the treatment of all Herpesvirus infections including HSV-1 "cold sores", HSV-2 "genital ulcers, VZV Shingles and Chickenpox. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants.

NV-387 has successfully completed a Phase I human clinical trial in healthy volunteers with no reported adverse events. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

Forward-looking statements: This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Media Contact:
NanoViricides, Inc.
info@nanoviricides.com

Public Relations Contact:
ir@nanoviricides.com

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire

• Collaboration enables integrated device-plus-AI offerings supporting scalable ECG analysis, visualization, and report generation

• Combination of single-lead wearable devices and AI algorithms creating a pathway towards cost-efficient Holter-style monitoring solutions

TORONTO, ON / ACCESS Newswire / January 20, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is pleased to announce a strategic collaboration with Movesense Ltd, a medical device manufacturer and wearable sensor technology provider based in Finland, designating Movesense as one of NeuralCloud’s primary ECG device partners.

The collaboration supports the development of bundled cardiac monitoring solutions that combine Movesense’s wearable single-lead ECG sensors with NeuralCloud’s AI-powered cardiac platforms, including MaxYield™, CardioYield™, and Insight360™. Together, these technologies enable high-quality ECG acquisition, automated signal enhancement, and scalable report generation across clinical, research, wellness, and performance environments.

Movesense’s programmable, lightweight wearable sensors-commonly deployed as chest-strap and body-worn single-lead medical ECG devices-offer a proven, flexible and cost-efficient hardware foundation. When paired with NeuralCloud’s AI-driven signal processing and visualization stack, the combined solution enables end-to-end ECG workflows that extend beyond traditional device-only or software-only approaches.

The collaboration also creates an opportunity to address segments traditionally served by higher-cost Holter monitoring systems. By pairing Movesense’s scalable wearable ECG sensors with AI-powered signal enhancement, labeling, and reporting, NeuralCloud aims to support solutions that can complement-and in select use cases potentially replace-conventional Holter workflows, while maintaining alignment with clinical standards and regulatory pathways.

Through Insight360™, users can generate customizable ECG reports using no-code, drag-and-drop dashboards designed for both everyday wellness users and professional clinical environments. CardioYield™ enables structured Holter-style review and reporting, while MaxYield™ serves as the underlying AI engine that denoises ECG signals, labels PQRST waveforms, and produces machine-readable interval data.

"This collaboration allows us to move beyond analytics in isolation and deliver a complete, integrated cardiac solution," said Esmat Naikyar, President of NeuralCloud and Chief Product Officer at AIML. "By working with Movesense as a core device partner, we can combine high-quality single-lead ECG capture with advanced AI algorithms to support new monitoring models, including pathways toward Holter-style analysis and reporting using more accessible devices."

"This partnership strengthens our operational and commercial flexibility," said Erik Suokas, Chief Operating Officer of AI/ML Innovations. "Movesense provides a proven, scalable device platform that allows us to bundle hardware and AI software into unified offerings. This approach supports faster deployment, broader market reach, and more competitive solutions across wellness, monitoring, and clinical use cases."

"Movesense was built to enable flexible, high-quality ECG acquisition across a wide range of applications," said Jussi Kaasinen, CEO of Movesense. "Partnering with NeuralCloud allows our wearable devices to be paired with advanced AI-driven analysis and reporting. Together, we can support innovative cardiac monitoring solutions that are scalable, cost-effective, and designed to integrate seamlessly into modern digital health workflows."

"This collaboration reflects our broader strategy to embed AI-powered cardiac intelligence directly into real-world workflows," added Paul Duffy, Executive Chairman and CEO of AI/ML Innovations. "By combining wearable ECG hardware with our software platforms, we strengthen our go-to-market position and expand our ability to deliver complete, device-enabled cardiac solutions."

About Movesense

Movesense Ltd is a leading wearable sensor technology company specializing in ECG (electrocardiogram), heart rate, heart rate variability (HRV), and motion sensing for medical, sports, wellness, and research applications. Based in Finland, and being ISO13485:2016 Certified medical device manufacturer, Movesense develops and manufactures scalable, lightweight, durable, and programmable wearable sensors designed to integrate seamlessly into custom digital health solutions.

Movesense devices support single-lead ECG acquisition, commonly used in chest-strap and body-worn configurations, and are available in both medical and non-medical variants, enabling deployment across regulated healthcare, performance monitoring, and consumer wellness environments. With open APIs, developer tools, and flexible firmware, Movesense enables partners to rapidly build, brand, and scale connected cardiac monitoring solutions.

About AI/ML Innovations Inc.

AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care.

AIML’s shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB).

For detailed information please see AIML’s website or the Company’s filed documents at www.sedarplus.ca .

Contact:

Blake Fallis (778) 405-0882
blake@aiml.health

On behalf of the Board of Directors:
Paul Duffy, Executive Chairman and CEO

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements – Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including risks associated with the implementation of the Company’s products and services. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including with respect to the nature and timing of future operations and the receipt of all applicable regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

View the original press release on ACCESS Newswire

How AI Driven Discovery and Authority Recognition Reshaped Client Selection in Legal Services

POST FALLS, IDAHO / ACCESS Newswire / January 19, 2026 / Background and Initial Challenge

A mid sized law firm with a strong local reputation reached an unexpected growth plateau after years of steady expansion. Despite continued investment in website improvements, branding, and general online visibility, inbound leads stalled and new client inquiries became inconsistent.

Leadership began noticing a shift in how potential clients described their discovery process. More than 60 percent of new inquiries referenced AI tools as part of their initial research, often before visiting any law firm website. In several cases, the firm was not mentioned at all in AI generated answers, despite strong historical performance in traditional search.

This gap revealed a new competitive risk. Visibility alone was no longer determining consideration.

A Fundamental Shift in How Clients Choose Firms

Client discovery behavior had changed. Prospective clients were no longer comparing five or ten firms across search results. Instead, they were asking direct questions such as who handles this type of case or which law firm is trusted for this issue.

AI systems increasingly responded with a single firm recommendation. Internal analysis showed that when the firm was not surfaced by AI tools, it was excluded from consideration entirely before any human interaction occurred.

In practice, this meant competitive differentiation was happening earlier than ever, often before branding, messaging, or credentials were reviewed.

The Strategic Approach

Trustpoint Xposure reframed the challenge as an authority recognition issue rather than a marketing quality problem. AI systems do not evaluate persuasive language, visual design, or claims of expertise. They evaluate consistency, validation, and corroborated signals across trusted third party environments.

The strategy focused on aligning the firm with how AI systems assess credibility. Key initiatives included strengthening structured AEO signals, reinforcing reputation management across independent platforms, and securing targeted media placement to establish clear external validation.

The objective was to ensure AI systems could confidently identify the firm as a reliable and authoritative entity without relying on the firm’s own marketing materials.

Trustpoint Xposure is currently the only PR agency in the United States that has completed formal AEO certification and applies that certification through direct media access and AI answer validation.

Implementation and Early Results

Within four to six weeks of implementing the new structure, AI generated answers began to change. The firm started appearing consistently in response to relevant legal queries, often positioned as the primary recommendation rather than one of many options.

During intake calls, more than 45 percent of new clients referenced AI tools directly, frequently repeating language seen in AI summaries. Lead quality improved first, followed by increased volume.

Measurable Business Impact

Within three months, inbound leads increased by more than 110 percent. Average sales cycles shortened by approximately 30 percent because trust had already been established before the first conversation.

Revenue stabilized quickly and then returned to sustained growth, enabling leadership to move forward with initiatives that had previously been delayed. These included hiring additional staff, expanding practice areas, and increasing long term investment in authority driven visibility efforts designed to perform in AI mediated discovery environments.

Key Takeaways for Professional Services Firms

This case illustrates that success in AI driven discovery is not driven by short term tactics or incremental optimization. Firms asking how to rank first in AI search must focus on durable authority that is recognizable outside their own website.

Authority must be structured, validated, and reinforced across trusted third party environments that AI systems can independently verify. Firms that adapt early gain a compounding advantage. They are not simply found more often. They are selected before the first call ever takes place.

Media Contact
Jack Smith
Media Director
contact@trustpointxposure.com

SOURCE: Trustpoint Xposure

View the original press release on ACCESS Newswire